PHAT vs AMGN: Which Stock is Better?
Side-by-side comparison of Phathom Pharmaceuticals Inc and Amgen Inc in 2026
PHAT
Phathom Pharmaceuticals Inc
—
AMGN
Amgen Inc
$368.77
Key Metrics Comparison
| Metric | PHAT | AMGN | Winner |
|---|---|---|---|
| Market Cap | $622.74M | $188.67B | AMGN |
| P/E Ratio | N/A | 24.33 | AMGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze PHAT
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHAT or AMGN a better investment?
Comparing PHAT and AMGN: Phathom Pharmaceuticals Inc has a market cap of $622.74M while Amgen Inc has $188.67B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHAT and AMGN?
PHAT (Phathom Pharmaceuticals Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHAT or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PHAT or AMGN?
Both PHAT and AMGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: PHAT or AMGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: PHAT or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $188.67B compared to $622.74M for PHAT.
Should I buy PHAT or AMGN in 2026?
Both PHAT and AMGN have investment merit. PHAT trades at $N/A while AMGN trades at $368.77. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHAT and AMGN stock?
Key differences: Market Cap ($622.74M vs $188.67B), P/E Ratio (N/A vs 24.3x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy PHAT or AMGN in 2026?
The choice between PHAT and AMGN depends on your investment goals. AMGN shows higher revenue growth (0.0%). AMGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between PHAT and AMGN?
PHAT (Phathom Pharmaceuticals Inc) has a market cap of $622.74M, while AMGN (Amgen Inc) has a market cap of $188.67B. AMGN is the larger company by market value.